May 6, 2015

Drug Factsheets

 Health Home >> Medications 

Dimetane Expectorant-DC

(brompheniramine maleate - phenylephrine HCl - guaifenesin - hydrocodone bitartrate)

DIN (Drug Identification Number)


How does Dimetane Expectorant-DC work? What will it do for me?

This combination product contains four medications: brompheniramine, phenylephrine, guaifenesin, and hydrocodone.

Hydrocodone belongs to the group of medications called narcotic analgesics and cough suppressants. It works by blocking pain signals that are sent out by the brain to various areas of the body and reduces coughing by acting in the brain to dull the cough reflex.

Brompheniramine belongs to the group of medications called antihistamines and helps to relieve sneezing and runny nose.

Phenylephrine belongs to the group of medications called nasal decongestants and is used to decrease nasal stuffiness.

Guaifenesin belongs to the group of medications called expectorants. This medication helps to loosen mucus so it can be coughed up.

This medication is used for the temporary relief of coughing and stuffy or runny nose that is associated with allergies, the common cold, or chest infections.



People who read this article also read about:

How should I use Dimetane Expectorant-DC?

The usual adult dose is 10 mL (2 teaspoons) every 6 hours as needed.







What form(s) does Dimetane Expectorant-DC come in?

Each 5 mL of cherry-red liquid, with menthol and raspberry taste and odour, contains hydrocodone bitartrate 1.8 mg, brompheniramine maleate 2 mg, phenylephrine HCl 5 mg, and guaifenesin 100 mg. Nonmedicinal ingredients: alcohol, citric acid, D&C Red No. 33, FD&C Red No. 40, flavours, glycerin, invert sugar, sodium benzoate, and water.

Who should NOT take Dimetane Expectorant-DC?

Do not use this medication if you:

  • are allergic to brompheniramine, phenylephrine, guaifenesin hydrocodone, or any of the ingredients of the medication
  • are allergic to hydrocodone-like narcotics or other similar antihistamines, or decongestants
  • are at risk of blocked intestines
  • are intending to use the medication to treat lower respiratory tract symptoms such as asthma
  • are taking an MAO inhibitor (e.g., phenelzine, tranylcypromine) or have taken one in the past 2 weeks
  • have a head injury or increased pressure inside the brain
  • have seizures

Continued... 1 | 2 | Next



